Analyst Price Targets — BSX
Latest News for BSX
111 Capital purchased a new stake in shares of Boston Scientific Corporation (NYSE: BSX) during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 30,717 shares of the medical equipment provider's stock, valued at approximately $2,999,000. Other hedge funds and other institutional investors
New York, New York--(Newsfile Corp. - March 2, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Boston Scientific Corporation ("Boston Scientific Corporation") (NYSE: BSX) concerning potential violations of the federal securities laws. On February 4, 2026, Boston Scientific reported fourth-quarter 2025 results.
APG Asset Management N.V. lifted its position in shares of Boston Scientific Corporation (NYSE: BSX) by 5.8% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,061,037 shares of the medical equipment provider's stock after buying an additional
The latest trading day saw Boston Scientific (BSX) settling at $76.85, representing a +1.45% change from its previous close.
DNB Asset Management AS cut its stake in Boston Scientific Corporation (NYSE: BSX) by 9.6% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 399,330 shares of the medical equipment provider's stock after selling 42,244 shares during the period.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.